DEB0026326MA - - Google Patents
Info
- Publication number
- DEB0026326MA DEB0026326MA DEB0026326MA DE B0026326M A DEB0026326M A DE B0026326MA DE B0026326M A DEB0026326M A DE B0026326MA
- Authority
- DE
- Germany
- Prior art keywords
- dimethyl
- salicylamide
- phenyl
- dimethylamino
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
- XAEWZDYWZHIUCT-UHFFFAOYSA-N desipramine hydrochloride Chemical class [H+].[Cl-].C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 XAEWZDYWZHIUCT-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- RLISWLLILOTWGG-UHFFFAOYSA-N salamidacetic acid Chemical compound NC(=O)C1=CC=CC=C1OCC(O)=O RLISWLLILOTWGG-UHFFFAOYSA-N 0.000 description 1
- 229950000417 salamidacetic acid Drugs 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2659152C2 (de) | Stabile antibiotische wäßrige Lösung | |
| CH174811A (de) | Verfahren zur Darstellung von Tropasäure-2,2-dimethyl-3-diäthylaminopropanolester. | |
| DEB0026326MA (enrdf_load_stackoverflow) | ||
| DE939929C (de) | Verfahren zur Herstellung einer Molekuelverbindung des 1-Phenyl-2, 3-dimethyl-4-dimethylamino-5-pyrazolons | |
| DE223695C (enrdf_load_stackoverflow) | ||
| DE156901C (enrdf_load_stackoverflow) | ||
| DE2516252C3 (de) | Elektrolyt für die galvanische Goldabscheidung | |
| DE621230C (de) | Verfahren zur Herstellung von klar loeslichem Speisesalz aus Alkalichloriden und Saeuren und schwer loeslichen Salzen des Magnesiums, der Erdalkalien und der Schwermetalle | |
| DE633786C (de) | Verfahren zur Herstellung von Komplexverbindungen des 1, 3-Dimethylxanthins | |
| DE960457C (de) | Verfahren zur Herstellung von leicht loeslichen Salzen des Di-(4-amidino-phenyl)-triazen-(N-1, 3) | |
| DE338427C (de) | Verfahren zur Herstellung von Additionsprodukten des Hexamethylentetramins | |
| DE231092C (enrdf_load_stackoverflow) | ||
| DE264390C (enrdf_load_stackoverflow) | ||
| DE1093647B (de) | Feste Phosphatierungsmittel zur Herstellung von Phosphatierungsloesungen | |
| DE1768556B2 (de) | Verfahren zur Herstellung wässriger Lösungen von Sulfobernsfeinsäureestersalzen bzw. Sulfobernsteinsäureamidsalzen und Schwefel | |
| DE116806C (enrdf_load_stackoverflow) | ||
| DE229814C (enrdf_load_stackoverflow) | ||
| DE192783C (de) | Verfahren zur Darstellung von Hydrazin | |
| DEF0017098MA (enrdf_load_stackoverflow) | ||
| DE268103C (enrdf_load_stackoverflow) | ||
| EP0222198B1 (de) | Erzeugnisse enthaltend Amitriptylinoxid zur parenteralen Verabreichung bei der Therapie von Depressionen | |
| DE320480C (de) | Verfahren zur Darstellung von Derivaten des Hydrastinins | |
| AT158301B (de) | Verfahren zur Herstellung von Vitamin B1. | |
| DE332456C (de) | Verfahren zur Herstellung einer geschmacklich neutralen, kolloidalen Loesung aus Kasein und Magnesia | |
| DE175593C (enrdf_load_stackoverflow) |